We know that we're likely to melt down when things get hectic, …
"At least two-thirds of all (study) participants underestimated…
Updated: Wednesday, 28 Nov 2012, 4:35 PM EST
Published : Wednesday, 28 Nov 2012, 4:35 PM EST
BUFFALO, N.Y. (AP) - A western New York company says it has signed a $4.6 million contract with Russia to develop anti-infection drugs.
Buffalo-based Cleveland BioLabs Inc. says the contract with the Ministry of Industry and Trade of the Russian Federation was issued under the federation's "Pharma 2020" pharmaceutical development initiative.
The contract announced Tuesday focuses on Xenomycins, a family of compounds being developed as potential treatments for infectious diseases. It's being handled through Panacela Labs, a biotechnology startup company that was founded last year as a joint venture between Cleveland BioLabs and a Russian investment company.
| With WIVB.com's new commenting system you don't need to register. You can login with an existing Facebook, Yahoo!, Google, or Twitter account and more. If you have a WIVB.com login you can still use it in our Participate section. |
This may be hard to believe in the aftermath of Superstorm Sandy, but an annual …
Advertisement